These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9071622

  • 1. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
    Ozgoztasi O, Baydar I.
    Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
    [Abstract] [Full Text] [Related]

  • 2. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
    Asilian A, Davami M.
    Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
    [Abstract] [Full Text] [Related]

  • 3. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
    el-On J, Sulitzeanu A, Schnur LF.
    Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981
    [Abstract] [Full Text] [Related]

  • 4. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A, Joseph M, Feltis T, Morris SK.
    Am J Trop Med Hyg; 2016 Oct 05; 95(4):793-794. PubMed ID: 27549634
    [Abstract] [Full Text] [Related]

  • 5. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J, Halevy S, Grunwald MH, Weinrauch L.
    J Am Acad Dermatol; 1992 Aug 05; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
    Sahibzada NJ, Tareen AK, Khursheed T, Darr N.
    J Pak Med Assoc; 1996 Mar 05; 46(3):53-5. PubMed ID: 8991348
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
    Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben Ismail R.
    Am J Trop Med Hyg; 1995 Aug 05; 53(2):162-6. PubMed ID: 7677218
    [Abstract] [Full Text] [Related]

  • 8. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec 05; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 9. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, Bettaieb J, Gharbi A, Belhadj Hamida N, Boukthir A, Chlif S, Abdelhamid K, El Ahmadi Z, Louzir H, Mokni M, Morizot G, Buffet P, Smith PL, Kopydlowski KM, Kreishman-Deitrick M, Smith KS, Nielsen CJ, Ullman DR, Norwood JA, Thorne GD, McCarthy WF, Adams RC, Rice RM, Tang D, Berman J, Ransom J, Magill AJ, Grogl M.
    N Engl J Med; 2013 Feb 07; 368(6):524-32. PubMed ID: 23388004
    [Abstract] [Full Text] [Related]

  • 10. WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
    Ben Salah A, Buffet PA, Morizot G, Ben Massoud N, Zâatour A, Ben Alaya N, Haj Hamida NB, El Ahmadi Z, Downs MT, Smith PL, Dellagi K, Grögl M.
    PLoS Negl Trop Dis; 2009 Feb 07; 3(5):e432. PubMed ID: 19415122
    [Abstract] [Full Text] [Related]

  • 11. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Feb 07; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul 07; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 13. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N, Pascale JM, Jiménez AI, Norwood JA, Kreishman-Detrick M, Weina PJ, Lawrence K, McCarthy WF, Adams RC, Scott C, Ransom J, Tang D, Grogl M.
    PLoS Negl Trop Dis; 2019 May 07; 13(5):e0007253. PubMed ID: 31048871
    [Abstract] [Full Text] [Related]

  • 14. Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study.
    Bahamdan KA, Tallab TM, Johargi H, Nourad MM, Ibrahim K, el Sherbini AH, Karkashan E, Khare AK, Nauri MM.
    Int J Dermatol; 1997 Jan 07; 36(1):59-60. PubMed ID: 9071621
    [Abstract] [Full Text] [Related]

  • 15. Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana.
    el-On J, Cawich F, Evans DA, Weinrauch L.
    Int J Parasitol; 1993 Feb 07; 23(1):121-7. PubMed ID: 8468127
    [Abstract] [Full Text] [Related]

  • 16. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr 07; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 17. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A, Stipić T, Skerlev M, Basta-Juzbasić A.
    J Eur Acad Dermatol Venereol; 1999 Nov 07; 13(3):214-7. PubMed ID: 10642059
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of topical ketoconazole in cutaneous leishmaniasis.
    Abahusein A, Larbi EB, al-Khawajah A, al-Gindan Y, Jain S.
    East Afr Med J; 1992 Jan 07; 69(1):14-7. PubMed ID: 1628541
    [Abstract] [Full Text] [Related]

  • 19. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L, Cawich F, Craig P, Sosa JX, el-On J.
    J Am Acad Dermatol; 1993 Sep 07; 29(3):443-6. PubMed ID: 8349861
    [Abstract] [Full Text] [Related]

  • 20. Treatment of cutaneous leishmaniasis by photodynamic therapy.
    Gardlo K, Horska Z, Enk CD, Rauch L, Megahed M, Ruzicka T, Fritsch C.
    J Am Acad Dermatol; 2003 Jun 07; 48(6):893-6. PubMed ID: 12789181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.